PLDT
PHI
18.59
+0.50
+2.76%
PLDT
US · PHI
#2300 by market cap
Listed 1970
18.59
+0.50
+2.76%
Live - 5344 symbols - heartbeat 198s ago
· 2026-10-08 07:24
Pre-market
18.09
-2.69%
After-hours
18.59
0.00%
- Market cap
- 4.02B
- P/E (TTM)i
- 9.13
- P/Bi
- 1.89
- EPSi
- 2.11
- Div yieldi
- 8.28%
- 52W posi
- 34%
Reader sentiment
Are you bullish or bearish on PHI?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 0.54, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +0.72% YoY
Margins
- Gross margin
- 86.82%
- Operating margin
- 24.87%
- Net margin
- 13.10%
Key ratios & quality
- Enterprise valuei
- 295.73B
- PEG ratioi
- 0.23
- Altman Z-Scorei
- 0.54
PEG uses trailing P/E against the 3-year net income growth rate (39.82%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 162.91B | 169.19B | 181.00B | 192.19B | 204.36B | 210.95B | 216.83B | 218.39B |
| Gross profit | 142.99B | 152.12B | 166.56B | 175.57B | 184.09B | 185.44B | 189.10B | 189.59B |
| Selling & admin expenses | 53.72B | 42.90B | 45.71B | 45.98B | 51.28B | 46.25B | 42.26B | 39.61B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 23.09B | 45.23B | 46.51B | 45.81B | 979.00M | 45.13B | 54.81B | 54.32B |
| Pretax profit | 22.82B | 32.34B | 33.02B | 34.26B | 14.03B | 34.71B | 40.54B | 37.69B |
| Tax | 3.84B | 9.55B | 8.44B | 7.46B | 2.70B | 9.17B | 9.60B | 8.82B |
| Net profit | 18.97B | 22.79B | 24.58B | 26.68B | 10.74B | 25.50B | 30.94B | 28.87B |
| Basic EPS | 87 | 104 | 112 | 122 | 48 | 117 | 142 | 132 |
| Diluted EPS | 87.28 | 103.97 | 112.12 | 121.76 | 48.26 | 116.77 | 141.80 | 132.38 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 55.28B | 54.35B | 53.71B | 55.11B | 56.51B | 55.49B |
| Gross profit | 47.45B | 46.99B | 47.01B | 48.16B | 47.07B | 47.14B |
| Selling & admin expenses | 9.43B | 19.05B | 19.04B | 10.41B | 9.29B | 18.42B |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 15.60B | 14.82B | 12.34B | 11.57B | 14.59B | 14.44B |
| Pretax profit | 11.80B | 11.47B | 9.04B | 4.97B | 11.26B | 10.02B |
| Tax | 2.74B | 2.66B | 2.08B | 1.24B | 2.34B | 2.41B |
| Net profit | 9.06B | 8.81B | 6.96B | 3.73B | 8.92B | 7.62B |
| Basic EPS | 42 | 41 | 32 | 17 | 41 | 35 |
| Diluted EPS | 41.71 | 40.69 | 32.02 | 16.55 | 40.98 | 35.01 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 99.57B | 75.58B | 87.44B | 73.93B | 81.33B | 70.12B | 63.83B | 69.41B |
| Cash & ST investments | 61.43B | 35.68B | 48.57B | 33.42B | 25.80B | 17.09B | 11.00B | 12.24B |
| Inventory | 2.88B | 3.41B | 4.09B | 3.66B | 3.57B | 3.34B | 3.31B | 1.84B |
| Total assets | 482.75B | 525.03B | 575.85B | 626.33B | 624.16B | 609.52B | 623.28B | 634.83B |
| Total current liabilities | 192.61B | 204.45B | 213.54B | 224.27B | 247.00B | 196.67B | 188.46B | 159.14B |
| Short-term debt | 20.44B | 22.94B | 21.61B | 16.04B | 42.77B | 17.57B | 30.68B | 25.08B |
| Long-term debt | 155.84B | 172.83B | 205.20B | 241.08B | 217.29B | 243.15B | 258.25B | 278.87B |
| Total liabilities | 366,084,000,000.00 | 408,737,000,000.00 | 456,181,000,000.00 | 498,863,000,000.00 | 510,201,000,000.00 | 499,133,000,000.00 | 506,540,000,000.00 | 506,745,000,000.00 |
| Total equity | 116.67B | 116.29B | 119.67B | 127.47B | 113.96B | 110.39B | 116.74B | 128.08B |
| Retained earnings | 12.08B | 18.06B | 25.65B | 34.24B | 18.80B | 18.97B | 29.24B | 37.32B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 67.91B | 64.12B | 61.95B | 69.41B | 74.67B | 74.54B |
| Cash & ST investments | 14.66B | 11.62B | 10.38B | 12.24B | 15.00B | 12.68B |
| Inventory | 2.75B | 2.47B | 2.17B | 1.84B | 2.33B | 2.79B |
| Total assets | 626.67B | 629.62B | 629.56B | 634.83B | 639.56B | 638.28B |
| Total current liabilities | 187.79B | 174.08B | 163.38B | 159.14B | 179.85B | 168.59B |
| Short-term debt | 27.75B | 30.40B | 26.07B | 25.08B | 38.75B | 41.10B |
| Long-term debt | 262.90B | 269.28B | 280.13B | 278.87B | 266.39B | 267.01B |
| Total liabilities | 509,872,000,000.00 | 504,208,000,000.00 | 508,064,000,000.00 | 506,745,000,000.00 | 512,387,000,000.00 | 503,157,000,000.00 |
| Total equity | 116.80B | 125.41B | 121.49B | 128.08B | 127.17B | 135.12B |
| Retained earnings | 32.76B | 41.85B | 38.40B | 37.32B | 42.24B | 43.80B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 61.12B | 69.39B | 85.08B | 91.97B | 76.20B | 85.77B | 81.73B | 98.74B |
| Depreciation & amortization | 48.13B | 40.41B | 49.98B | 54.99B | 98.94B | 58.68B | 56.23B | 59.49B |
| Free cash flow | 13.85B | -19.00B | 6.98B | -12.01B | -19.35B | 7.33B | 13.45B | 35.66B |
| Dividends paid | -13.93B | -15.59B | -16.72B | -17.71B | -25.24B | -23.33B | -20.75B | -20.59B |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 51.65B | 24.37B | 40.24B | 23.91B | 25.21B | 16.18B | 10.01B | 11.87B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 24.55B | 22.16B | 29.06B | 22.97B | 22.75B | 23.03B |
| Depreciation & amortization | 13.07B | 13.12B | 15.63B | 17.67B | 14.28B | 14.27B |
| Free cash flow | 8.40B | 4.22B | 11.05B | 11.99B | 10.36B | 11.68B |
| Dividends paid | -39.00M | -10.17B | -10.36B | -14.00M | -19.00M | -9.92B |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 13.76B | 10.84B | 10.09B | 11.87B | 14.53B | 11.90B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 17.29 | 20.12 | 21.40 | 22.14 | 9.03 | 24.94 | 29.37 | 23.71 |
| ROA %i | 4.00 | 4.46 | 4.40 | 4.38 | 1.67 | 4.31 | 5.23 | 4.55 |
| ROIC %i | 8.11 | 8.94 | 9.08 | 8.97 | 4.79 | 8.89 | 10.10 | 8.96 |
| 5-year avg ROE %i | 18.16 | 17.15 | 17.86 | 18.68 | 18.00 | 19.28 | 20.84 | 21.30 |
| EBIT margin %i | 18.05 | 24.11 | 23.77 | 23.01 | 12.21 | 23.77 | 26.80 | 25.57 |
| FCF / sales %i | 8.41 | -- | 4.74 | -- | -- | 3.47 | 6.20 | 16.33 |
| Current ratioi | 0.52 | 0.37 | 0.41 | 0.33 | 0.33 | 0.36 | 0.34 | 0.44 |
| Quick ratioi | 0.46 | 0.29 | 0.34 | 0.25 | 0.22 | 0.23 | 0.23 | 0.28 |
| Debt / assetsi | 36.52 | 39.78 | 42.16 | 43.79 | 46.79 | 49.60 | 53.85 | 56.59 |
| LT debt / equityi | 139.33 | 166.79 | 192.50 | 210.43 | 230.32 | 271.97 | 265.38 | 264.40 |
| Interest coveragei | 4.29 | 4.82 | 4.30 | 4.31 | 2.17 | 3.67 | 3.77 | 3.08 |
| Revenue CAGR (3Y) %i | -1.62 | 0.79 | 4.43 | 5.66 | 6.50 | 5.24 | 4.10 | 2.24 |
| Net income CAGR (3Y) %i | -5.00 | 4.03 | 22.01 | 11.71 | -22.50 | 1.36 | 5.20 | 39.82 |
| FCF CAGR (3Y) %i | -19.58 | -- | -28.84 | -- | -- | 1.66 | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 28.66 | 27.08 | 25.33 | 23.71 | 23.67 | 21.46 |
| ROA %i | 5.04 | 5.09 | 4.68 | 4.55 | 4.49 | 4.35 |
| ROIC %i | 10.08 | 9.89 | 9.31 | 8.96 | 8.98 | 8.49 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 26.48 | 27.04 | 25.69 | 25.57 | 25.18 | 24.56 |
| FCF / sales %i | 7.73 | 5.71 | 8.06 | 16.33 | 17.13 | 20.40 |
| Current ratioi | 0.36 | 0.37 | 0.38 | 0.44 | 0.42 | 0.44 |
| Quick ratioi | 0.25 | 0.25 | 0.26 | 0.28 | 0.27 | 0.29 |
| Debt / assetsi | 53.76 | 55.20 | 56.91 | 56.59 | 55.87 | 56.56 |
| LT debt / equityi | 268.96 | 256.29 | 277.27 | 264.40 | 254.00 | 239.98 |
| Interest coveragei | 3.52 | 3.46 | 3.14 | 3.08 | 3.05 | 3.00 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Fixed Line is the largest reported line at 60.04% of revenue, across 3 reported segments.
- Wireless follows at 46.26%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Fixed Line60.04%
Wireless46.26%
Quote time 2026-10-08 07:24:33 · For reference only, not investment advice and not tailored to your situation.